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128 Supplementation with n-3 PUFA in CF patients: analysis of
exhaled breath condensate
L. Fila1, J. Brazova2, J. Musil1. 1Pulmonary Department, Charles University,
2nd School of Medicine, and University Hospital Motol, Prague, Czech Republic;
2Institute of Immunology, Charles University, 2nd School of Medicine, and
University Hospital Motol, Prague, Czech Republic
Background: supplementation with n-3 polyunsaturated fatty acids (PUFA) leads
to production of leukotriene (LT) B5, which is biologically less active than LTB4.
LTB4 is important chemoattractant in neutrophilic inﬂammation in CF lung disease.
Methods: nine F508del homozygous CF patients (5 females) aged 25.6±3.3
(mean±SD) years were treated for 6 weeks with n-3 PUFA (dosis corresponding to
1.3% of energy intake). Exhaled breath condensates (EBC) were collected before
and after treatment. pH and LTB4 concentration (pg/ml) were measured in EBC
samples.
Results: pH was increased (from 6.08±0.39 to 6.32±0.18; p = 0.013) and LTB4
concentration was decreased (from 227.3±195.0 to 134.9±67.3 pg/ml; p = 0.075)
in EBC after n-3 PUFA treatment.
Conclusion: LTB4 concentration in EBC tend to be lower after n-3 PUFA treatment
and EBC is signiﬁcantly less acidiﬁed, which may reﬂect less intense neutrophilic
inﬂammation.
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129 Long-term treatment with glucocorticoids in low doses restores
affected cytokine production in cystic ﬁbrosis patients
A.L. Pukhalsky, G.V. Shmarina, D.A. Pukhalskaya, L.V. Perederko,
N.Y. Kashirskaya, N.I. Kapranov. Research Centre for Medical Genetics,
Moscow, Russian Federation
Plasma levels of cytokines (TNF-a, IFNg, IL-4, IL-10, TGF-b1) and ACTH of 128
cystic ﬁbrosis (CF) patients and 100 healthy children (HC) have been compared.
CF patients were divided into three groups: without anti-inﬂammatory treatment
(WAT Group; n = 83), patients treated with alternated course of prednisolone (Pr
Group; 0.3−0.5mg/kg body weight every other day; n = 16), and patients treated
with azithromycin (Az Group; 500 mg orally three times a week; n = 37). The
patients of WAT Group demonstrated signiﬁcant elevation of plasma cytokines
including IL-10, IFNg, and TGF-b1 in comparison with HC (18.2 vs 6.8 ng/ml,
262 vs 15.6 pg/ml, and 70.7 vs 19.6 ng/ml respectively; all p< 0.001). It was also
noticed a trend to the decrease of TNF-a concentration in WAT Group (10.9 vs
17.1 pg/ml; p = 0.066). Surprisingly, we did not observe such changes in Pr Group:
the cytokine concentrations were not signiﬁcantly different from those observed in
HC. In Az Group the same but not so well-deﬁned tendency has been shown.
Thus, although plasma concentrations of TNF-a and IL-10 were not different
from corresponding data in HC, IFNg and TGF-b1 levels remained signiﬁcantly
higher (160.8 vs 15.6 pg/ml and 64.5 vs 19.6 pg/ml respectively; both p< 0.005).
It is important to note that CF patients demonstrated low plasma levels of ACTH
amounting 4.5 pg/ml in both WAT and Pr Groups and 3.6 pg/ml in Az Groups vs
9.2 pg/ml in HC (all p< 0.05). These data suggest that the permanent inﬂammation
in CF patients results in hypothalamic-pituitary-adrenal axis underactivity. It seems
that prolonged treatment with glucocorticoids or macrolides makes up for stress
hormones deﬁciency.
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Background: Measurement of cytokines in Exhaled Breath Condensate (EBC)
has been used in an attempt to qualify the degree of inﬂammation in the lower
respiratory tract. We speculated how inhalation of hypertonic saline (HS) might
affect the concentrations of cytokines.
Method: 10 CF-patients with chronic pseudomonas-infection and 10 healthy
controls received inhalations of HS (7%), 4ml. EBC was collected before and
immediately after inhalation. Samples were bubbled with argon for 15 minutes to
remove CO2, and pH was measured. Concentration of IL-1b, IL-6, IL-8 and IL-10
were measured using ultra-sensitive ELISA-kits.
Results: Inhalation of HS and EBC-collection was well tolerated by all subjects. We
found no difference in pH between or within groups. IL1b decreased signiﬁcantly
in CF-subjects (p< 0.05). We found more samples with concentration of IL-6 above
detection-level in the control-group (p< 0.03). We found no differences between or
within groups in concentrations of IL-6, IL-8 or IL-10.
Conclusion: Inhalation of HS and EBC-collection was well tolerated by all subjects.
HS induced reduction in IL1b concentration in CF subjects. Studies on larger groups
are needed to fully clarify the effect of HS on inﬂammatory markers in EBC.
Table 1: Measurements on EBC. Results shown as median (range). N equals number of samples with values above
detection-level.
Healthy Controls CF-Patients
Before N After N Before N After N
pH 6.28 (5.02−7.62) 10/10 6.83 (5.2−7.67) 10/10 6.63 (4.75−7.49) 10/10 6.34 (5.04−7.75) 10/10
IL1b n.d. n.d. n.d. n.d. 0.45 (0−2.59) 8/10 0.12 (0−0.66) 6/10
IL-6 0.01 (0−0.33) 4/10 0 (0−0.16) 2/10 0.01 (0−0.09) 1/10 0 (0−0.02) 0/10
IL-8 0 (0−0.41) 1/10 0 (0−0.46) 1/10 0.02 (0−0.08) 0/10 0.01 (0−0.52) 1/10
IL-10 0.21 (0−1.53) 5/10 0.41 (0−1.09) 8/10 0.39 (0−0.67) 6/10 0.49 (0−2.04) 7/10
131 Basophil activation test for the early diagnosis of allergic
bronchopulmonary aspergillosis (ABPA)
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ABPA is an immunologically mediated lung disease caused by hypersensitivity
to Aspergillus antigens. In Cystic Fibrosis (CF) patients ABPA has detrimental
effects. Prompt recognition and treatment of this disease is critical for the outcome.
Diagnosis is based on a combination of clinical and laboratory criteria (consensus
2003). These criteria are often ambiguous and the use of additional ones would
be useful in solving the diagnostic dilemma. Such a criterion could be the positive
Basophil Activation Test (BAT), which is the assessment of basophil activation
by ﬂow cytometry, after their in vitro stimulation with allergens, using CD63 and
CD203 as activation indexes.
The aim of this study was to investigate the diagnostic value of BAT for ABPA in
CF patients.
Material and Methods: Using A. fumigatus extract as allergen, BAT was applied
for 10 healthy controls (Group A) and a total of 18 CF patients: 10 with deﬁnite
ABPA diagnosis (Group B) and 8 with high level of suspicion for ABPA (Group C).
In all the patients serum total IgE and speciﬁc IgE for A. fumigatus (M3)
were determined by ﬂuoro-enzyme-immunoassay (FEIA). Skin brick tests with
A. fumigatus extract were performed in all 18 patients.
Results and Discussion: Whereas BAT was negative in healthy controls, positive
BAT to A. fumigatus extract was a constant ﬁnding in all Group B patients. Among
Group C patients, in a follow up period of 1 year, 2/2 with negative BAT have not
developed ABPA, 5/6 with positive BAT have developed the disease, and 1/6 of the
same subgroup has had increasing values of total and speciﬁc IgE.
Conclusion: Our study points towards a high diagnostic value of BAT for the early
recognition of ABPA, though an additional number of patients is needed.
